Profile
Full Name
Viking Therapeutics, Inc.Ticker Symbol
VKTXExchange
NASDAQSector
HealthcareIndustry
BiotechnologyCountry
United StatesIPO
April 28, 2015Indexes
Not includedEmployees
36Key Details
Price
$24.99(-2.61%)
Market cap
$2.81B(Mid cap)
Last Dividend
-
TTM Dividend yield
-
Annual revenue
-
Annual EPS
-$1.01(-10.99% YoY)
Next earnings date
Jul 24, 2025Next ex-dividend date
N/ANext split date
N/APrice
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Price Performance
Price Range
Capitalization
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Market cap
Shares Outstanding
Technical Indicators
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
Viking Therapeutics doesn't have historical dividend data
Income Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Revenue
EPS
Profit
Expenses
EBIT & EBITDA
Balance Sheet
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Assets
Liabilities
Debt
Equity & Capital
Cash Flow Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cashflow Activities
CAPEX
Free Cash Flow
Profitability Ratios
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Margins
ROA & ROE
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Leverage
Risk & Stability
Analyst ratings
Recent major analysts updates
Apr 24, 25 Morgan Stanley
OverweightApr 24, 25 HC Wainwright & Co.
BuyApr 17, 25 HC Wainwright & Co.
BuyApr 8, 25 Goldman Sachs
NeutralMar 26, 25 HC Wainwright & Co.
BuyMar 11, 25 HC Wainwright & Co.
BuyFeb 13, 25 Scotiabank
Sector OutperformFeb 7, 25 Maxim Group
BuyFeb 7, 25 Citigroup
NeutralFeb 7, 25 B. Riley Securities
BuyInstitutional Ownership
- What is the ticker symbol for Viking Therapeutics?
- Does Viking Therapeutics pay dividends?
- What sector is Viking Therapeutics in?
- What industry is Viking Therapeutics in?
- What country is Viking Therapeutics based in?
- When did Viking Therapeutics go public?
- Is Viking Therapeutics in the S&P 500?
- Is Viking Therapeutics in the NASDAQ 100?
- Is Viking Therapeutics in the Dow Jones?
- When was Viking Therapeutics's last earnings report?
- When does Viking Therapeutics report earnings?
- Should I buy Viking Therapeutics stock now?
What is the ticker symbol for Viking Therapeutics?
The ticker symbol for Viking Therapeutics is NASDAQ:VKTX
Does Viking Therapeutics pay dividends?
No, Viking Therapeutics does not pay dividends
What sector is Viking Therapeutics in?
Viking Therapeutics is in the Healthcare sector
What industry is Viking Therapeutics in?
Viking Therapeutics is in the Biotechnology industry
What country is Viking Therapeutics based in?
Viking Therapeutics is headquartered in United States
When did Viking Therapeutics go public?
Viking Therapeutics's initial public offering (IPO) was on April 28, 2015
Is Viking Therapeutics in the S&P 500?
No, Viking Therapeutics is not included in the S&P 500 index
Is Viking Therapeutics in the NASDAQ 100?
No, Viking Therapeutics is not included in the NASDAQ 100 index
Is Viking Therapeutics in the Dow Jones?
No, Viking Therapeutics is not included in the Dow Jones index
When was Viking Therapeutics's last earnings report?
Viking Therapeutics's most recent earnings report was on Apr 23, 2025
When does Viking Therapeutics report earnings?
The next expected earnings date for Viking Therapeutics is Jul 24, 2025
Should I buy Viking Therapeutics stock now?
As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions